Subcutaneous Infliximab and Assumptions of Response in Ileal Crohn’s Disease: Does Route of Administration Matter?

Clinical Gastroenterology and Hepatology 2026

View at publisher

Authors: John David Chetwood, Robert David Little

DOI: 10.1016/j.cgh.2026.02.021

Cited by: 0

References: 5

Fields of Study & Subjects

Inflammatory Bowel Disease Rheumatoid Arthritis Research and Therapies Ocular Diseases and Behçet’s Syndrome

References 5